Equilis Prequenza Te - European Medicines Agency - Islam
|
Equilis Prequenza
EMA/414991/2008 EMEA/V/C/094 EPAR summary for the public Equilis Prequenza Equine influenza vaccine This document is a summary of the European Public Assessment Report |
Does equilis prequenza Te reduce active immunity against tetanus in horses?
Concurrent use of Equilis Prequenza Te and Tetanus-Serum from Intervet may reduce active immunity against tetanus compared to horses vaccinated with Equilis Prequenza Te in the absence of tetanus antitoxin serum. Zero days. 5. To stimulate active immunity against Equine influenza and tetanus in horses. 6.
Why has equilis prequenza Te been approved?
equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid Active immunisation of horses from six months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.
What is equilis Te?
Equilis Te may only be prescribed by your veterinary practitioner from whom advice should be sought. Equilis Te contains Tetanus toxoid 40 Lf1 and the following adjuvants:Purified Saponin 375 μgCholesterol 125 μgPhosphatidylcholine 62.5 μgIt contains no chemical adjuvant but uses innovative ISCOM-Matrix technology.
|
PDF / 47MB - Open Research Online oroopenacuk - The Open
Laboratories Agency by Dr Nicky Commander and the Brucella immunology a major complication of brucellosis and considered a medical emergency, (made by Pfizer, a vaccine for Bordetella bronchiseptica in dogs) and Equilis® 1 ( mouse macrophages) cells obtained from the European Collection of Cell Cultures |
